Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on SN158. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110937987B details a high-yield synthetic route for SN158, a PPAR agonist. Achieves >99% purity via recrystallization, eliminating column chromatography for cost-effective manufacturing.